Moderna’s Covid Shot Gets Regulatory Nod in India for Imports

75
16
Favorite

Moderna’s Covid Shot Gets Regulatory Nod in India for Imports

Bloomberg2021-06-29

Indemnity details still being discussed, official says India has fully vaccinated only 4% of its population India’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（16）

Annalz
·2021-06-30
MRNA protect the world
Reply
Like
Report
SaLena
·2021-06-29
Stock
Reply
Like
Report
Carrotcake
·2021-06-29
Huejejjr
Reply
Like
Report
paxson
·2021-06-29
Fly fly fly
Reply
Like
Report
EMforever
·2021-06-29
fly fly fly
Reply
1
Report
Missypampam
·2021-06-29
Very encouraging!
Reply
3
Report
LegenDMKL
·2021-06-29
Mooon
Reply
4
Report
Jackalwolf
·2021-06-29
Like
Reply
4
Report
Kelaier
·2021-06-29
Like and comment and I’ll do the same !
Reply
5
Report
Fold Replies
- Lsh12:
  done. tks.
  2021-06-29
  Reply
  Report
- LEOWWEILEONG:
  done
  2021-06-29
  Reply
  Report
LoveYa
·2021-06-29
Good
Reply
5
Report
Fold Replies
- Moola:
  Yo
  2021-06-29
  Reply
  Report
- 2TheMoon:
  Yes
  2021-06-29
  Reply
  Report
2TheMoon
·2021-06-29
??
Reply
5
Report
Fold Replies
- LoveYa:
  Good
  2021-06-29
  Reply
  Report
- ShaneC:
  Yeaaa
  2021-06-29
  Reply
  Report
benlauhh
·2021-06-29
Great
Reply
4
Report
Maximus88
·2021-06-29
Gg
Reply
1
Report
EdwinHoHoHo
·2021-06-29
Countries especially India should quickly look into getting their citizens vaccined this way they could resume operations.
Reply
2
Report
OPP
·2021-06-29
If only we can have Modena here!!
Reply
4
Report
Fold Replies
- geneviL:
  why not? get your contry health department to approve. [龇牙]
  2021-06-30
  Reply
  Report
BigMac8885
·2021-06-29
Pls like and comment
Reply
Like
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1144845089?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-06-29 21:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144845089","market":"us","top_or_hot":-1,"title":"Moderna’s Covid Shot Gets Regulatory Nod in India for Imports","media":"Bloomberg","content":"<div>\n<p>Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp\">Source Link</a>\n\n</div>\n","source":"lsy1584095487587","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna’s Covid Shot Gets Regulatory Nod in India for Imports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna’s Covid Shot Gets Regulatory Nod in India for Imports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp","article_id":"1144845089","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144845089","pubTimestamp":1624972212,"columns":[],"sourceInfo":{"source_id":"lsy1584095487587","name":"Bloomberg"},"weMediaInfo":null,"summary":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its pop","collect":0,"end_time":0,"defaultTopTitle":"bloomberg.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"莫德纳的Covid镜头在印度获得了进口监管机构的认可","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9},"content_text":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.\nThe Drugs Controller General of India cleared pharmaceutical company Cipla Ltd. to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.\n“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”\nPaul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of indemnity to protect against legal liability in case of adverse effects.\nIndia had in April fast-tracked approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.\nIndia has been in talks with both Pfizer Inc. and Moderna to import additional inoculations needed for its immunization program.\nDespite halting all exports in April and benefiting from a huge vaccine industry, India has fully vaccinated just over 4% of its vast population.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":153088897,"gmtCreate":1624985748919,"gmtModify":1703849615218,"author":{"id":"3577089953267281","authorId":"3577089953267281","name":"Annalz","avatar":"https://static.tigerbbs.com/ffd285ab6189bb61da4b48c3e149eedc","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3577089953267281","authorIdStr":"3577089953267281"},"htmlText":"MRNA protect the world&nbsp;","listText":"MRNA protect the world&nbsp;","text":"MRNA protect the world","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/153088897","repostId":1144845089,"repostType":4,"repost":{"id":"1144845089","kind":"news","pubTimestamp":1624972212,"share":"https://ttm.financial/m/news/1144845089?lang=&edition=fundamental","pubTime":"2021-06-29 21:10","market":"us","language":"en","title":"Moderna’s Covid Shot Gets Regulatory Nod in India for Imports","url":"https://stock-news.laohu8.com/highlight/detail?id=1144845089","media":"Bloomberg","summary":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its pop","content":"<ul>\n <li>Indemnity details still being discussed, official says</li>\n <li>India has fully vaccinated only 4% of its population</li>\n</ul>\n<p>India’s drug regulator has cleared the imports of&nbsp;Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.</p>\n<p>The Drugs Controller General of India cleared pharmaceutical company&nbsp;Cipla Ltd.&nbsp;to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.</p>\n<p>“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”</p>\n<p>Paul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of&nbsp;indemnity&nbsp;to protect against legal liability in case of adverse effects.</p>\n<p>India had in April&nbsp;fast-tracked&nbsp;approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.</p>\n<p>India has been in talks with both&nbsp;Pfizer Inc.&nbsp;and Moderna to import additional inoculations needed for its immunization program.</p>\n<p>Despite halting all exports in April and benefiting from a huge vaccine industry, India has&nbsp;fully vaccinated&nbsp;just over 4% of its vast population.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna’s Covid Shot Gets Regulatory Nod in India for Imports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna’s Covid Shot Gets Regulatory Nod in India for Imports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144845089","content_text":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.\nThe Drugs Controller General of India cleared pharmaceutical company Cipla Ltd. to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.\n“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”\nPaul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of indemnity to protect against legal liability in case of adverse effects.\nIndia had in April fast-tracked approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.\nIndia has been in talks with both Pfizer Inc. and Moderna to import additional inoculations needed for its immunization program.\nDespite halting all exports in April and benefiting from a huge vaccine industry, India has fully vaccinated just over 4% of its vast population.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":159755457,"gmtCreate":1624981745779,"gmtModify":1703849517097,"author":{"id":"3585445602485006","authorId":"3585445602485006","name":"SaLena","avatar":"https://static.tigerbbs.com/77b07b1cbf1b3609f8e8b30a8ca94901","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3585445602485006","authorIdStr":"3585445602485006"},"htmlText":"Stock&nbsp;","listText":"Stock&nbsp;","text":"Stock","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159755457","repostId":1144845089,"repostType":4,"repost":{"id":"1144845089","kind":"news","pubTimestamp":1624972212,"share":"https://ttm.financial/m/news/1144845089?lang=&edition=fundamental","pubTime":"2021-06-29 21:10","market":"us","language":"en","title":"Moderna’s Covid Shot Gets Regulatory Nod in India for Imports","url":"https://stock-news.laohu8.com/highlight/detail?id=1144845089","media":"Bloomberg","summary":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its pop","content":"<ul>\n <li>Indemnity details still being discussed, official says</li>\n <li>India has fully vaccinated only 4% of its population</li>\n</ul>\n<p>India’s drug regulator has cleared the imports of&nbsp;Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.</p>\n<p>The Drugs Controller General of India cleared pharmaceutical company&nbsp;Cipla Ltd.&nbsp;to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.</p>\n<p>“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”</p>\n<p>Paul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of&nbsp;indemnity&nbsp;to protect against legal liability in case of adverse effects.</p>\n<p>India had in April&nbsp;fast-tracked&nbsp;approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.</p>\n<p>India has been in talks with both&nbsp;Pfizer Inc.&nbsp;and Moderna to import additional inoculations needed for its immunization program.</p>\n<p>Despite halting all exports in April and benefiting from a huge vaccine industry, India has&nbsp;fully vaccinated&nbsp;just over 4% of its vast population.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna’s Covid Shot Gets Regulatory Nod in India for Imports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna’s Covid Shot Gets Regulatory Nod in India for Imports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144845089","content_text":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.\nThe Drugs Controller General of India cleared pharmaceutical company Cipla Ltd. to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.\n“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”\nPaul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of indemnity to protect against legal liability in case of adverse effects.\nIndia had in April fast-tracked approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.\nIndia has been in talks with both Pfizer Inc. and Moderna to import additional inoculations needed for its immunization program.\nDespite halting all exports in April and benefiting from a huge vaccine industry, India has fully vaccinated just over 4% of its vast population.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":159457683,"gmtCreate":1624977945042,"gmtModify":1703849377924,"author":{"id":"3573166225931101","authorId":"3573166225931101","name":"Carrotcake","avatar":"https://static.tigerbbs.com/afb7b52104c648bff57fa67033090329","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3573166225931101","authorIdStr":"3573166225931101"},"htmlText":"&nbsp; Huejejjr","listText":"&nbsp; Huejejjr","text":"Huejejjr","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159457683","repostId":1144845089,"repostType":4,"repost":{"id":"1144845089","kind":"news","pubTimestamp":1624972212,"share":"https://ttm.financial/m/news/1144845089?lang=&edition=fundamental","pubTime":"2021-06-29 21:10","market":"us","language":"en","title":"Moderna’s Covid Shot Gets Regulatory Nod in India for Imports","url":"https://stock-news.laohu8.com/highlight/detail?id=1144845089","media":"Bloomberg","summary":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its pop","content":"<ul>\n <li>Indemnity details still being discussed, official says</li>\n <li>India has fully vaccinated only 4% of its population</li>\n</ul>\n<p>India’s drug regulator has cleared the imports of&nbsp;Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.</p>\n<p>The Drugs Controller General of India cleared pharmaceutical company&nbsp;Cipla Ltd.&nbsp;to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.</p>\n<p>“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”</p>\n<p>Paul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of&nbsp;indemnity&nbsp;to protect against legal liability in case of adverse effects.</p>\n<p>India had in April&nbsp;fast-tracked&nbsp;approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.</p>\n<p>India has been in talks with both&nbsp;Pfizer Inc.&nbsp;and Moderna to import additional inoculations needed for its immunization program.</p>\n<p>Despite halting all exports in April and benefiting from a huge vaccine industry, India has&nbsp;fully vaccinated&nbsp;just over 4% of its vast population.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna’s Covid Shot Gets Regulatory Nod in India for Imports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna’s Covid Shot Gets Regulatory Nod in India for Imports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144845089","content_text":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.\nThe Drugs Controller General of India cleared pharmaceutical company Cipla Ltd. to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.\n“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”\nPaul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of indemnity to protect against legal liability in case of adverse effects.\nIndia had in April fast-tracked approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.\nIndia has been in talks with both Pfizer Inc. and Moderna to import additional inoculations needed for its immunization program.\nDespite halting all exports in April and benefiting from a huge vaccine industry, India has fully vaccinated just over 4% of its vast population.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":159453996,"gmtCreate":1624977716815,"gmtModify":1703849368710,"author":{"id":"3587023069153443","authorId":"3587023069153443","name":"paxson","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3587023069153443","authorIdStr":"3587023069153443"},"htmlText":"Fly fly fly","listText":"Fly fly fly","text":"Fly fly fly","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159453996","repostId":1144845089,"repostType":4,"repost":{"id":"1144845089","kind":"news","pubTimestamp":1624972212,"share":"https://ttm.financial/m/news/1144845089?lang=&edition=fundamental","pubTime":"2021-06-29 21:10","market":"us","language":"en","title":"Moderna’s Covid Shot Gets Regulatory Nod in India for Imports","url":"https://stock-news.laohu8.com/highlight/detail?id=1144845089","media":"Bloomberg","summary":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its pop","content":"<ul>\n <li>Indemnity details still being discussed, official says</li>\n <li>India has fully vaccinated only 4% of its population</li>\n</ul>\n<p>India’s drug regulator has cleared the imports of&nbsp;Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.</p>\n<p>The Drugs Controller General of India cleared pharmaceutical company&nbsp;Cipla Ltd.&nbsp;to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.</p>\n<p>“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”</p>\n<p>Paul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of&nbsp;indemnity&nbsp;to protect against legal liability in case of adverse effects.</p>\n<p>India had in April&nbsp;fast-tracked&nbsp;approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.</p>\n<p>India has been in talks with both&nbsp;Pfizer Inc.&nbsp;and Moderna to import additional inoculations needed for its immunization program.</p>\n<p>Despite halting all exports in April and benefiting from a huge vaccine industry, India has&nbsp;fully vaccinated&nbsp;just over 4% of its vast population.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna’s Covid Shot Gets Regulatory Nod in India for Imports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna’s Covid Shot Gets Regulatory Nod in India for Imports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144845089","content_text":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.\nThe Drugs Controller General of India cleared pharmaceutical company Cipla Ltd. to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.\n“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”\nPaul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of indemnity to protect against legal liability in case of adverse effects.\nIndia had in April fast-tracked approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.\nIndia has been in talks with both Pfizer Inc. and Moderna to import additional inoculations needed for its immunization program.\nDespite halting all exports in April and benefiting from a huge vaccine industry, India has fully vaccinated just over 4% of its vast population.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":159459814,"gmtCreate":1624977685038,"gmtModify":1703849367883,"author":{"id":"3581768776429785","authorId":"3581768776429785","name":"EMforever","avatar":"https://static.tigerbbs.com/ba863bd38fca4e924e6722519bf62a8e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581768776429785","authorIdStr":"3581768776429785"},"htmlText":"fly fly fly","listText":"fly fly fly","text":"fly fly fly","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159459814","repostId":1144845089,"repostType":4,"repost":{"id":"1144845089","kind":"news","pubTimestamp":1624972212,"share":"https://ttm.financial/m/news/1144845089?lang=&edition=fundamental","pubTime":"2021-06-29 21:10","market":"us","language":"en","title":"Moderna’s Covid Shot Gets Regulatory Nod in India for Imports","url":"https://stock-news.laohu8.com/highlight/detail?id=1144845089","media":"Bloomberg","summary":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its pop","content":"<ul>\n <li>Indemnity details still being discussed, official says</li>\n <li>India has fully vaccinated only 4% of its population</li>\n</ul>\n<p>India’s drug regulator has cleared the imports of&nbsp;Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.</p>\n<p>The Drugs Controller General of India cleared pharmaceutical company&nbsp;Cipla Ltd.&nbsp;to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.</p>\n<p>“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”</p>\n<p>Paul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of&nbsp;indemnity&nbsp;to protect against legal liability in case of adverse effects.</p>\n<p>India had in April&nbsp;fast-tracked&nbsp;approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.</p>\n<p>India has been in talks with both&nbsp;Pfizer Inc.&nbsp;and Moderna to import additional inoculations needed for its immunization program.</p>\n<p>Despite halting all exports in April and benefiting from a huge vaccine industry, India has&nbsp;fully vaccinated&nbsp;just over 4% of its vast population.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna’s Covid Shot Gets Regulatory Nod in India for Imports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna’s Covid Shot Gets Regulatory Nod in India for Imports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144845089","content_text":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.\nThe Drugs Controller General of India cleared pharmaceutical company Cipla Ltd. to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.\n“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”\nPaul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of indemnity to protect against legal liability in case of adverse effects.\nIndia had in April fast-tracked approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.\nIndia has been in talks with both Pfizer Inc. and Moderna to import additional inoculations needed for its immunization program.\nDespite halting all exports in April and benefiting from a huge vaccine industry, India has fully vaccinated just over 4% of its vast population.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":159568242,"gmtCreate":1624974601986,"gmtModify":1703849203756,"author":{"id":"3576253972603112","authorId":"3576253972603112","name":"Missypampam","avatar":"https://static.tigerbbs.com/25229e3836d82fa58ebf76e52af13677","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3576253972603112","authorIdStr":"3576253972603112"},"htmlText":"Very encouraging!&nbsp;","listText":"Very encouraging!&nbsp;","text":"Very encouraging!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159568242","repostId":1144845089,"repostType":4,"repost":{"id":"1144845089","kind":"news","pubTimestamp":1624972212,"share":"https://ttm.financial/m/news/1144845089?lang=&edition=fundamental","pubTime":"2021-06-29 21:10","market":"us","language":"en","title":"Moderna’s Covid Shot Gets Regulatory Nod in India for Imports","url":"https://stock-news.laohu8.com/highlight/detail?id=1144845089","media":"Bloomberg","summary":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its pop","content":"<ul>\n <li>Indemnity details still being discussed, official says</li>\n <li>India has fully vaccinated only 4% of its population</li>\n</ul>\n<p>India’s drug regulator has cleared the imports of&nbsp;Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.</p>\n<p>The Drugs Controller General of India cleared pharmaceutical company&nbsp;Cipla Ltd.&nbsp;to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.</p>\n<p>“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”</p>\n<p>Paul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of&nbsp;indemnity&nbsp;to protect against legal liability in case of adverse effects.</p>\n<p>India had in April&nbsp;fast-tracked&nbsp;approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.</p>\n<p>India has been in talks with both&nbsp;Pfizer Inc.&nbsp;and Moderna to import additional inoculations needed for its immunization program.</p>\n<p>Despite halting all exports in April and benefiting from a huge vaccine industry, India has&nbsp;fully vaccinated&nbsp;just over 4% of its vast population.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna’s Covid Shot Gets Regulatory Nod in India for Imports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna’s Covid Shot Gets Regulatory Nod in India for Imports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144845089","content_text":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.\nThe Drugs Controller General of India cleared pharmaceutical company Cipla Ltd. to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.\n“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”\nPaul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of indemnity to protect against legal liability in case of adverse effects.\nIndia had in April fast-tracked approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.\nIndia has been in talks with both Pfizer Inc. and Moderna to import additional inoculations needed for its immunization program.\nDespite halting all exports in April and benefiting from a huge vaccine industry, India has fully vaccinated just over 4% of its vast population.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":159561504,"gmtCreate":1624974568708,"gmtModify":1703849202448,"author":{"id":"3554795205677745","authorId":"3554795205677745","name":"LegenDMKL","avatar":"https://community-static.tradeup.com/news/da8186043c706766afc0b29b25855823","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":6,"crmLevelSwitch":0,"idStr":"3554795205677745","authorIdStr":"3554795205677745"},"htmlText":"Mooon","listText":"Mooon","text":"Mooon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159561504","repostId":1144845089,"repostType":4,"repost":{"id":"1144845089","kind":"news","pubTimestamp":1624972212,"share":"https://ttm.financial/m/news/1144845089?lang=&edition=fundamental","pubTime":"2021-06-29 21:10","market":"us","language":"en","title":"Moderna’s Covid Shot Gets Regulatory Nod in India for Imports","url":"https://stock-news.laohu8.com/highlight/detail?id=1144845089","media":"Bloomberg","summary":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its pop","content":"<ul>\n <li>Indemnity details still being discussed, official says</li>\n <li>India has fully vaccinated only 4% of its population</li>\n</ul>\n<p>India’s drug regulator has cleared the imports of&nbsp;Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.</p>\n<p>The Drugs Controller General of India cleared pharmaceutical company&nbsp;Cipla Ltd.&nbsp;to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.</p>\n<p>“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”</p>\n<p>Paul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of&nbsp;indemnity&nbsp;to protect against legal liability in case of adverse effects.</p>\n<p>India had in April&nbsp;fast-tracked&nbsp;approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.</p>\n<p>India has been in talks with both&nbsp;Pfizer Inc.&nbsp;and Moderna to import additional inoculations needed for its immunization program.</p>\n<p>Despite halting all exports in April and benefiting from a huge vaccine industry, India has&nbsp;fully vaccinated&nbsp;just over 4% of its vast population.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna’s Covid Shot Gets Regulatory Nod in India for Imports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna’s Covid Shot Gets Regulatory Nod in India for Imports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144845089","content_text":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.\nThe Drugs Controller General of India cleared pharmaceutical company Cipla Ltd. to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.\n“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”\nPaul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of indemnity to protect against legal liability in case of adverse effects.\nIndia had in April fast-tracked approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.\nIndia has been in talks with both Pfizer Inc. and Moderna to import additional inoculations needed for its immunization program.\nDespite halting all exports in April and benefiting from a huge vaccine industry, India has fully vaccinated just over 4% of its vast population.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":159584745,"gmtCreate":1624974445587,"gmtModify":1703849195732,"author":{"id":"3586305762771621","authorId":"3586305762771621","name":"Jackalwolf","avatar":"https://static.tigerbbs.com/f55b4843e3937de7580f25943edecfca","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586305762771621","authorIdStr":"3586305762771621"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159584745","repostId":1144845089,"repostType":4,"repost":{"id":"1144845089","kind":"news","pubTimestamp":1624972212,"share":"https://ttm.financial/m/news/1144845089?lang=&edition=fundamental","pubTime":"2021-06-29 21:10","market":"us","language":"en","title":"Moderna’s Covid Shot Gets Regulatory Nod in India for Imports","url":"https://stock-news.laohu8.com/highlight/detail?id=1144845089","media":"Bloomberg","summary":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its pop","content":"<ul>\n <li>Indemnity details still being discussed, official says</li>\n <li>India has fully vaccinated only 4% of its population</li>\n</ul>\n<p>India’s drug regulator has cleared the imports of&nbsp;Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.</p>\n<p>The Drugs Controller General of India cleared pharmaceutical company&nbsp;Cipla Ltd.&nbsp;to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.</p>\n<p>“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”</p>\n<p>Paul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of&nbsp;indemnity&nbsp;to protect against legal liability in case of adverse effects.</p>\n<p>India had in April&nbsp;fast-tracked&nbsp;approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.</p>\n<p>India has been in talks with both&nbsp;Pfizer Inc.&nbsp;and Moderna to import additional inoculations needed for its immunization program.</p>\n<p>Despite halting all exports in April and benefiting from a huge vaccine industry, India has&nbsp;fully vaccinated&nbsp;just over 4% of its vast population.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna’s Covid Shot Gets Regulatory Nod in India for Imports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna’s Covid Shot Gets Regulatory Nod in India for Imports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144845089","content_text":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.\nThe Drugs Controller General of India cleared pharmaceutical company Cipla Ltd. to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.\n“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”\nPaul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of indemnity to protect against legal liability in case of adverse effects.\nIndia had in April fast-tracked approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.\nIndia has been in talks with both Pfizer Inc. and Moderna to import additional inoculations needed for its immunization program.\nDespite halting all exports in April and benefiting from a huge vaccine industry, India has fully vaccinated just over 4% of its vast population.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":159501924,"gmtCreate":1624973188368,"gmtModify":1703849133175,"author":{"id":"3586164144986773","authorId":"3586164144986773","name":"Kelaier","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586164144986773","authorIdStr":"3586164144986773"},"htmlText":"Like and comment and I’ll do the same !","listText":"Like and comment and I’ll do the same !","text":"Like and comment and I’ll do the same !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/159501924","repostId":1144845089,"repostType":4,"repost":{"id":"1144845089","kind":"news","pubTimestamp":1624972212,"share":"https://ttm.financial/m/news/1144845089?lang=&edition=fundamental","pubTime":"2021-06-29 21:10","market":"us","language":"en","title":"Moderna’s Covid Shot Gets Regulatory Nod in India for Imports","url":"https://stock-news.laohu8.com/highlight/detail?id=1144845089","media":"Bloomberg","summary":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its pop","content":"<ul>\n <li>Indemnity details still being discussed, official says</li>\n <li>India has fully vaccinated only 4% of its population</li>\n</ul>\n<p>India’s drug regulator has cleared the imports of&nbsp;Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.</p>\n<p>The Drugs Controller General of India cleared pharmaceutical company&nbsp;Cipla Ltd.&nbsp;to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.</p>\n<p>“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”</p>\n<p>Paul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of&nbsp;indemnity&nbsp;to protect against legal liability in case of adverse effects.</p>\n<p>India had in April&nbsp;fast-tracked&nbsp;approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.</p>\n<p>India has been in talks with both&nbsp;Pfizer Inc.&nbsp;and Moderna to import additional inoculations needed for its immunization program.</p>\n<p>Despite halting all exports in April and benefiting from a huge vaccine industry, India has&nbsp;fully vaccinated&nbsp;just over 4% of its vast population.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna’s Covid Shot Gets Regulatory Nod in India for Imports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna’s Covid Shot Gets Regulatory Nod in India for Imports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144845089","content_text":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.\nThe Drugs Controller General of India cleared pharmaceutical company Cipla Ltd. to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.\n“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”\nPaul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of indemnity to protect against legal liability in case of adverse effects.\nIndia had in April fast-tracked approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.\nIndia has been in talks with both Pfizer Inc. and Moderna to import additional inoculations needed for its immunization program.\nDespite halting all exports in April and benefiting from a huge vaccine industry, India has fully vaccinated just over 4% of its vast population.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5069476,"gmtCreate":1624973886214,"gmtModify":1663230283544,"authorId":3583572791217717,"author":{"id":3583572791217717,"idStr":"3583572791217717","authorId":3583572791217717,"name":"Lsh12","avatar":"https://static.tigerbbs.com/6321d7615da9181e53013ad0f965085b","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":159501924,"type":1,"supId":0,"prevId":0,"content":"done. tks.","text":"done. tks.","html":"done. tks."},{"id":5069583,"gmtCreate":1624974292174,"gmtModify":1663230282343,"authorId":3579520946980191,"author":{"id":3579520946980191,"idStr":"3579520946980191","authorId":3579520946980191,"name":"LEOWWEILEONG","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":159501924,"type":1,"supId":5069476,"prevId":0,"content":"done","text":"done","html":"done"}],"langContent":"EN"},{"id":159275686,"gmtCreate":1624972865845,"gmtModify":1703849124585,"author":{"id":"3581808565569357","authorId":"3581808565569357","name":"LoveYa","avatar":"https://static.tigerbbs.com/e498cbeb8cee6edb617285daad526d2c","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3581808565569357","authorIdStr":"3581808565569357"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/159275686","repostId":1144845089,"repostType":4,"repost":{"id":"1144845089","kind":"news","pubTimestamp":1624972212,"share":"https://ttm.financial/m/news/1144845089?lang=&edition=fundamental","pubTime":"2021-06-29 21:10","market":"us","language":"en","title":"Moderna’s Covid Shot Gets Regulatory Nod in India for Imports","url":"https://stock-news.laohu8.com/highlight/detail?id=1144845089","media":"Bloomberg","summary":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its pop","content":"<ul>\n <li>Indemnity details still being discussed, official says</li>\n <li>India has fully vaccinated only 4% of its population</li>\n</ul>\n<p>India’s drug regulator has cleared the imports of&nbsp;Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.</p>\n<p>The Drugs Controller General of India cleared pharmaceutical company&nbsp;Cipla Ltd.&nbsp;to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.</p>\n<p>“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”</p>\n<p>Paul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of&nbsp;indemnity&nbsp;to protect against legal liability in case of adverse effects.</p>\n<p>India had in April&nbsp;fast-tracked&nbsp;approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.</p>\n<p>India has been in talks with both&nbsp;Pfizer Inc.&nbsp;and Moderna to import additional inoculations needed for its immunization program.</p>\n<p>Despite halting all exports in April and benefiting from a huge vaccine industry, India has&nbsp;fully vaccinated&nbsp;just over 4% of its vast population.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna’s Covid Shot Gets Regulatory Nod in India for Imports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna’s Covid Shot Gets Regulatory Nod in India for Imports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144845089","content_text":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.\nThe Drugs Controller General of India cleared pharmaceutical company Cipla Ltd. to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.\n“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”\nPaul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of indemnity to protect against legal liability in case of adverse effects.\nIndia had in April fast-tracked approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.\nIndia has been in talks with both Pfizer Inc. and Moderna to import additional inoculations needed for its immunization program.\nDespite halting all exports in April and benefiting from a huge vaccine industry, India has fully vaccinated just over 4% of its vast population.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5069554,"gmtCreate":1624974160057,"gmtModify":1663230281440,"authorId":3563236857658111,"author":{"id":3563236857658111,"idStr":"3563236857658111","authorId":3563236857658111,"name":"Moola","avatar":"https://static.itradeup.com/news/b16c15008b428ee5865485305ad01cec","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":159275686,"type":1,"supId":0,"prevId":0,"content":"Yo","text":"Yo","html":"Yo"},{"id":5069222,"gmtCreate":1624972920628,"gmtModify":1663230280049,"authorId":3580510466646622,"author":{"id":3580510466646622,"idStr":"3580510466646622","authorId":3580510466646622,"name":"2TheMoon","avatar":"https://static.tigerbbs.com/10c30fc9030f34204462b3421477f8c0","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":159275686,"type":1,"supId":0,"prevId":0,"content":"Yes","text":"Yes","html":"Yes"}],"langContent":"EN"},{"id":159272611,"gmtCreate":1624972816933,"gmtModify":1703849123282,"author":{"id":"3580510466646622","authorId":"3580510466646622","name":"2TheMoon","avatar":"https://static.tigerbbs.com/10c30fc9030f34204462b3421477f8c0","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3580510466646622","authorIdStr":"3580510466646622"},"htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/159272611","repostId":1144845089,"repostType":4,"repost":{"id":"1144845089","kind":"news","pubTimestamp":1624972212,"share":"https://ttm.financial/m/news/1144845089?lang=&edition=fundamental","pubTime":"2021-06-29 21:10","market":"us","language":"en","title":"Moderna’s Covid Shot Gets Regulatory Nod in India for Imports","url":"https://stock-news.laohu8.com/highlight/detail?id=1144845089","media":"Bloomberg","summary":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its pop","content":"<ul>\n <li>Indemnity details still being discussed, official says</li>\n <li>India has fully vaccinated only 4% of its population</li>\n</ul>\n<p>India’s drug regulator has cleared the imports of&nbsp;Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.</p>\n<p>The Drugs Controller General of India cleared pharmaceutical company&nbsp;Cipla Ltd.&nbsp;to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.</p>\n<p>“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”</p>\n<p>Paul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of&nbsp;indemnity&nbsp;to protect against legal liability in case of adverse effects.</p>\n<p>India had in April&nbsp;fast-tracked&nbsp;approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.</p>\n<p>India has been in talks with both&nbsp;Pfizer Inc.&nbsp;and Moderna to import additional inoculations needed for its immunization program.</p>\n<p>Despite halting all exports in April and benefiting from a huge vaccine industry, India has&nbsp;fully vaccinated&nbsp;just over 4% of its vast population.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna’s Covid Shot Gets Regulatory Nod in India for Imports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna’s Covid Shot Gets Regulatory Nod in India for Imports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144845089","content_text":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.\nThe Drugs Controller General of India cleared pharmaceutical company Cipla Ltd. to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.\n“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”\nPaul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of indemnity to protect against legal liability in case of adverse effects.\nIndia had in April fast-tracked approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.\nIndia has been in talks with both Pfizer Inc. and Moderna to import additional inoculations needed for its immunization program.\nDespite halting all exports in April and benefiting from a huge vaccine industry, India has fully vaccinated just over 4% of its vast population.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5069214,"gmtCreate":1624972882461,"gmtModify":1663230279828,"authorId":3581808565569357,"author":{"id":3581808565569357,"idStr":"3581808565569357","authorId":3581808565569357,"name":"LoveYa","avatar":"https://static.tigerbbs.com/e498cbeb8cee6edb617285daad526d2c","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":159272611,"type":1,"supId":0,"prevId":0,"content":"Good","text":"Good","html":"Good"},{"id":5069443,"gmtCreate":1624973778929,"gmtModify":1631889772252,"authorId":3581424918112979,"author":{"id":3581424918112979,"idStr":"3581424918112979","authorId":3581424918112979,"name":"ShaneC","avatar":"https://static.tigerbbs.com/c067f9baa675e4063b0bea4dab0738e7","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.10","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":3,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":159272611,"type":1,"supId":0,"prevId":0,"content":"Yeaaa","text":"Yeaaa","html":"Yeaaa"}],"langContent":"EN"},{"id":159273816,"gmtCreate":1624972643535,"gmtModify":1703849118050,"author":{"id":"3577336591268984","authorId":"3577336591268984","name":"benlauhh","avatar":"https://static.tigerbbs.com/3ee4a98f8cae9c1852df6f63da10a6ec","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3577336591268984","authorIdStr":"3577336591268984"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159273816","repostId":1144845089,"repostType":4,"repost":{"id":"1144845089","kind":"news","pubTimestamp":1624972212,"share":"https://ttm.financial/m/news/1144845089?lang=&edition=fundamental","pubTime":"2021-06-29 21:10","market":"us","language":"en","title":"Moderna’s Covid Shot Gets Regulatory Nod in India for Imports","url":"https://stock-news.laohu8.com/highlight/detail?id=1144845089","media":"Bloomberg","summary":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its pop","content":"<ul>\n <li>Indemnity details still being discussed, official says</li>\n <li>India has fully vaccinated only 4% of its population</li>\n</ul>\n<p>India’s drug regulator has cleared the imports of&nbsp;Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.</p>\n<p>The Drugs Controller General of India cleared pharmaceutical company&nbsp;Cipla Ltd.&nbsp;to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.</p>\n<p>“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”</p>\n<p>Paul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of&nbsp;indemnity&nbsp;to protect against legal liability in case of adverse effects.</p>\n<p>India had in April&nbsp;fast-tracked&nbsp;approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.</p>\n<p>India has been in talks with both&nbsp;Pfizer Inc.&nbsp;and Moderna to import additional inoculations needed for its immunization program.</p>\n<p>Despite halting all exports in April and benefiting from a huge vaccine industry, India has&nbsp;fully vaccinated&nbsp;just over 4% of its vast population.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna’s Covid Shot Gets Regulatory Nod in India for Imports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna’s Covid Shot Gets Regulatory Nod in India for Imports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144845089","content_text":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.\nThe Drugs Controller General of India cleared pharmaceutical company Cipla Ltd. to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.\n“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”\nPaul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of indemnity to protect against legal liability in case of adverse effects.\nIndia had in April fast-tracked approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.\nIndia has been in talks with both Pfizer Inc. and Moderna to import additional inoculations needed for its immunization program.\nDespite halting all exports in April and benefiting from a huge vaccine industry, India has fully vaccinated just over 4% of its vast population.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":159270401,"gmtCreate":1624972583403,"gmtModify":1703849115605,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"htmlText":"Gg","listText":"Gg","text":"Gg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159270401","repostId":1144845089,"repostType":4,"repost":{"id":"1144845089","kind":"news","pubTimestamp":1624972212,"share":"https://ttm.financial/m/news/1144845089?lang=&edition=fundamental","pubTime":"2021-06-29 21:10","market":"us","language":"en","title":"Moderna’s Covid Shot Gets Regulatory Nod in India for Imports","url":"https://stock-news.laohu8.com/highlight/detail?id=1144845089","media":"Bloomberg","summary":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its pop","content":"<ul>\n <li>Indemnity details still being discussed, official says</li>\n <li>India has fully vaccinated only 4% of its population</li>\n</ul>\n<p>India’s drug regulator has cleared the imports of&nbsp;Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.</p>\n<p>The Drugs Controller General of India cleared pharmaceutical company&nbsp;Cipla Ltd.&nbsp;to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.</p>\n<p>“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”</p>\n<p>Paul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of&nbsp;indemnity&nbsp;to protect against legal liability in case of adverse effects.</p>\n<p>India had in April&nbsp;fast-tracked&nbsp;approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.</p>\n<p>India has been in talks with both&nbsp;Pfizer Inc.&nbsp;and Moderna to import additional inoculations needed for its immunization program.</p>\n<p>Despite halting all exports in April and benefiting from a huge vaccine industry, India has&nbsp;fully vaccinated&nbsp;just over 4% of its vast population.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna’s Covid Shot Gets Regulatory Nod in India for Imports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna’s Covid Shot Gets Regulatory Nod in India for Imports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144845089","content_text":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.\nThe Drugs Controller General of India cleared pharmaceutical company Cipla Ltd. to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.\n“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”\nPaul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of indemnity to protect against legal liability in case of adverse effects.\nIndia had in April fast-tracked approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.\nIndia has been in talks with both Pfizer Inc. and Moderna to import additional inoculations needed for its immunization program.\nDespite halting all exports in April and benefiting from a huge vaccine industry, India has fully vaccinated just over 4% of its vast population.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":159270160,"gmtCreate":1624972560350,"gmtModify":1703849114950,"author":{"id":"3581555128898037","authorId":"3581555128898037","name":"EdwinHoHoHo","avatar":"https://static.tigerbbs.com/f711273b850a35e529d1ddb7f8adc8fc","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3581555128898037","authorIdStr":"3581555128898037"},"htmlText":"Countries especially India should quickly look into getting their citizens vaccined this way they could resume operations.&nbsp;","listText":"Countries especially India should quickly look into getting their citizens vaccined this way they could resume operations.&nbsp;","text":"Countries especially India should quickly look into getting their citizens vaccined this way they could resume operations.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159270160","repostId":1144845089,"repostType":4,"repost":{"id":"1144845089","kind":"news","pubTimestamp":1624972212,"share":"https://ttm.financial/m/news/1144845089?lang=&edition=fundamental","pubTime":"2021-06-29 21:10","market":"us","language":"en","title":"Moderna’s Covid Shot Gets Regulatory Nod in India for Imports","url":"https://stock-news.laohu8.com/highlight/detail?id=1144845089","media":"Bloomberg","summary":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its pop","content":"<ul>\n <li>Indemnity details still being discussed, official says</li>\n <li>India has fully vaccinated only 4% of its population</li>\n</ul>\n<p>India’s drug regulator has cleared the imports of&nbsp;Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.</p>\n<p>The Drugs Controller General of India cleared pharmaceutical company&nbsp;Cipla Ltd.&nbsp;to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.</p>\n<p>“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”</p>\n<p>Paul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of&nbsp;indemnity&nbsp;to protect against legal liability in case of adverse effects.</p>\n<p>India had in April&nbsp;fast-tracked&nbsp;approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.</p>\n<p>India has been in talks with both&nbsp;Pfizer Inc.&nbsp;and Moderna to import additional inoculations needed for its immunization program.</p>\n<p>Despite halting all exports in April and benefiting from a huge vaccine industry, India has&nbsp;fully vaccinated&nbsp;just over 4% of its vast population.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna’s Covid Shot Gets Regulatory Nod in India for Imports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna’s Covid Shot Gets Regulatory Nod in India for Imports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144845089","content_text":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.\nThe Drugs Controller General of India cleared pharmaceutical company Cipla Ltd. to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.\n“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”\nPaul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of indemnity to protect against legal liability in case of adverse effects.\nIndia had in April fast-tracked approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.\nIndia has been in talks with both Pfizer Inc. and Moderna to import additional inoculations needed for its immunization program.\nDespite halting all exports in April and benefiting from a huge vaccine industry, India has fully vaccinated just over 4% of its vast population.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":159270087,"gmtCreate":1624972539949,"gmtModify":1703849114788,"author":{"id":"3587030474832187","authorId":"3587030474832187","name":"OPP","avatar":"https://static.tigerbbs.com/9d08e95ca3ed272bd428558fc0aae8bc","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3587030474832187","authorIdStr":"3587030474832187"},"htmlText":"If only we can have Modena here!!&nbsp;","listText":"If only we can have Modena here!!&nbsp;","text":"If only we can have Modena here!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/159270087","repostId":1144845089,"repostType":4,"repost":{"id":"1144845089","kind":"news","pubTimestamp":1624972212,"share":"https://ttm.financial/m/news/1144845089?lang=&edition=fundamental","pubTime":"2021-06-29 21:10","market":"us","language":"en","title":"Moderna’s Covid Shot Gets Regulatory Nod in India for Imports","url":"https://stock-news.laohu8.com/highlight/detail?id=1144845089","media":"Bloomberg","summary":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its pop","content":"<ul>\n <li>Indemnity details still being discussed, official says</li>\n <li>India has fully vaccinated only 4% of its population</li>\n</ul>\n<p>India’s drug regulator has cleared the imports of&nbsp;Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.</p>\n<p>The Drugs Controller General of India cleared pharmaceutical company&nbsp;Cipla Ltd.&nbsp;to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.</p>\n<p>“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”</p>\n<p>Paul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of&nbsp;indemnity&nbsp;to protect against legal liability in case of adverse effects.</p>\n<p>India had in April&nbsp;fast-tracked&nbsp;approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.</p>\n<p>India has been in talks with both&nbsp;Pfizer Inc.&nbsp;and Moderna to import additional inoculations needed for its immunization program.</p>\n<p>Despite halting all exports in April and benefiting from a huge vaccine industry, India has&nbsp;fully vaccinated&nbsp;just over 4% of its vast population.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna’s Covid Shot Gets Regulatory Nod in India for Imports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna’s Covid Shot Gets Regulatory Nod in India for Imports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144845089","content_text":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.\nThe Drugs Controller General of India cleared pharmaceutical company Cipla Ltd. to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.\n“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”\nPaul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of indemnity to protect against legal liability in case of adverse effects.\nIndia had in April fast-tracked approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.\nIndia has been in talks with both Pfizer Inc. and Moderna to import additional inoculations needed for its immunization program.\nDespite halting all exports in April and benefiting from a huge vaccine industry, India has fully vaccinated just over 4% of its vast population.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5076047,"gmtCreate":1625019019548,"gmtModify":1663230316546,"authorId":3571224998869358,"author":{"id":3571224998869358,"idStr":"3571224998869358","authorId":3571224998869358,"name":"geneviL","avatar":"https://static.tigerbbs.com/3fe6dc35659e6302f18e6a7a15cf3ef1","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":159270087,"type":1,"supId":0,"prevId":0,"content":"why not? get your contry health department to approve.  [龇牙]","text":"why not? get your contry health department to approve.  [龇牙]","html":"why not? get your contry health department to approve.  [龇牙]"}],"langContent":"EN"},{"id":159246185,"gmtCreate":1624972357447,"gmtModify":1703849108143,"author":{"id":"3579506230138289","authorId":"3579506230138289","name":"BigMac8885","avatar":"https://static.tigerbbs.com/e583c75322dd4651672938ebba8683b7","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3579506230138289","authorIdStr":"3579506230138289"},"htmlText":"Pls like and comment","listText":"Pls like and comment","text":"Pls like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159246185","repostId":1144845089,"repostType":4,"repost":{"id":"1144845089","kind":"news","pubTimestamp":1624972212,"share":"https://ttm.financial/m/news/1144845089?lang=&edition=fundamental","pubTime":"2021-06-29 21:10","market":"us","language":"en","title":"Moderna’s Covid Shot Gets Regulatory Nod in India for Imports","url":"https://stock-news.laohu8.com/highlight/detail?id=1144845089","media":"Bloomberg","summary":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its pop","content":"<ul>\n <li>Indemnity details still being discussed, official says</li>\n <li>India has fully vaccinated only 4% of its population</li>\n</ul>\n<p>India’s drug regulator has cleared the imports of&nbsp;Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.</p>\n<p>The Drugs Controller General of India cleared pharmaceutical company&nbsp;Cipla Ltd.&nbsp;to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.</p>\n<p>“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”</p>\n<p>Paul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of&nbsp;indemnity&nbsp;to protect against legal liability in case of adverse effects.</p>\n<p>India had in April&nbsp;fast-tracked&nbsp;approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.</p>\n<p>India has been in talks with both&nbsp;Pfizer Inc.&nbsp;and Moderna to import additional inoculations needed for its immunization program.</p>\n<p>Despite halting all exports in April and benefiting from a huge vaccine industry, India has&nbsp;fully vaccinated&nbsp;just over 4% of its vast population.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna’s Covid Shot Gets Regulatory Nod in India for Imports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna’s Covid Shot Gets Regulatory Nod in India for Imports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144845089","content_text":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.\nThe Drugs Controller General of India cleared pharmaceutical company Cipla Ltd. to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.\n“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”\nPaul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of indemnity to protect against legal liability in case of adverse effects.\nIndia had in April fast-tracked approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.\nIndia has been in talks with both Pfizer Inc. and Moderna to import additional inoculations needed for its immunization program.\nDespite halting all exports in April and benefiting from a huge vaccine industry, India has fully vaccinated just over 4% of its vast population.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":75,"commentSize":16,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}